Research Awards

Research Leadership Award

Nominations are due Friday, September 27th, 2019.

To nominate an individual for the Research Leadership award, click HERE.

The winner of this award will have their travel, accommodation, and conference fees paid to attend the Meeting of the Minds conference in Toronto on November 15 and 16th, 2019.​

They will be recognized at the Meeting of the Minds conference and have an opportunity to present their work. 

This award recognizes an individual who has demonstrated leadership and contributed significantly to advancing Crohn's and colitis research in Canada and has made an exceptional leadership contribution to the mission of Crohn’s and Colitis Canada. 

Nominated by their fellow scientists, recipients of the Research Leadership Award have made an exceptional contribution to Crohn’s and Colitis Canada’s Promise to cure Crohn’s disease and ulcerative colitis and improve the lives of children and adults living with these chronic diseases.

Nomination criteria: 

IBD scientists and researchers in Canada are eligible to be nominated. Nominations can be submitted by fellow scientists and IBD researchers. 

Submitting a Nomination

Nominees must complete the online application form below. Please note, applications are no longer being accepted via email or mail. If you encounter any difficulties with the online application forms, please contact research@crohnsandcolitis.ca

To nominate an individual for the Research Leadership award, click HERE.

Past Winners include:

2019      Dr. Charles Bernstein, Winnipeg, MB
2018      Dr. Laura Sly, Vancouver, BC

Rising Star Award

Nominations are due Friday, September 27th, 2019.

To nominate an individual for the Rising Star award, click HERE.

The winner of this award will have their travel, accommodation, and conference fees paid to attend the Meeting of the Minds conference in Toronto on November 15 and 16th, 2019​.


They will be recognized at the Meeting of the Minds conference and have an opportunity to present their work. 

This award recognizes an outstanding investigator in the early stages of his/her career. This award acknowledges the basic or clinical research accomplishments of a junior/newly emerging investigator in the field of Inflammatory Bowel Disease, within 5 years of their first faculty appointment. The five year period criterion will be extended for individuals who have taken extended leaves of absence due to life circumstances such as parental or sick leave.

Nominated by their fellow scientists, recipients of the Rising Star Award are innovative and productive leaders who are advancing Crohn's and colitis research in Canada and have made an outstanding contribution to the mission of Crohn’s and Colitis Canada. 

Nomination criteria:

Nominations can be submitted by fellow scientists and IBD researchers. IBD scientists and researchers in Canada within 5 years of their first faculty appointment are eligible to be nominated.

Submitting a Nomination

Nominees must complete the online application form available on the Crohn’s and Colitis Canada website. Please note, applications are no longer being accepted via email or mail. If you encounter any difficulties with the online application forms, please contact research@crohnsandcolitis.ca

To nominate an individual for the Rising Star award, click HERE.

Past Winners include:

2019      Dr. Neeraj Narula, Hamilton, ON
2018      Dr. Sanjay Murthy, Ottawa, ON
2017      Dr. Reena Khanna, London, ON
2016      Dr. Eric Benchimol, Nepean, ON

Contact information 

If you have any questions about Crohn's and Colitis Canada grant programs or awards, please do not hesitate to connect with us. Direct your questions to:

Research Grants Administrator
Telephone: (416) 920-5035 ext. 252
Email: research@crohnsandcolitis.ca 

  • Canada has among the highest incidence rates of Crohn's and colitis in the world.
  • 1 in 140 Canadians lives with Crohn’s or colitis.
  • Families new to Canada are developing these diseases for the first time.
  • Incidence of Crohn’s in Canadian kids under 10 has doubled since 1995.
  • People are most commonly diagnosed before age 30.

Other Areas of Interest